Fresenius | FRE - Operating Expenses

Stock Price
51.72
Daily Change
-0.34 -0.65%
Monthly
7.59%
Yearly
41.54%
Q1 Forecast
50.68

Fresenius reported EUR4.91B in Operating Expenses for its fiscal quarter ending in September of 2025.





Operating Expenses Change Date
Akzo Nobel EUR 2.16B 95M Dec/2025
Alcon AG USD 2.28B 67M Sep/2025
AstraZeneca USD 12.53B 4.16B Dec/2025
BASF EUR 13.84B 1.11B Sep/2025
Bayer EUR 10.2B 523M Sep/2025
Beiersdorf EUR 4.37B 143M Jun/2025
DaVita Healthcare Partners USD 3.04B 3.61B Dec/2025
Demant DKK 9.63B 241M Dec/2025
E.ON EUR 15.72B 442M Sep/2025
Essilor EUR 13.09B 1.07B Dec/2025
Fresenius EUR 4.91B 110M Sep/2025
Fresenius Medical Care EUR 4.43B 73.91M Sep/2025
Getinge SEK 9.99B 2.3B Dec/2024
Givaudan CHF 1.5B 1.35B Jun/2024
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
GN Store Nord DKK 4.11B 490M Dec/2025
GRIFOLS EUR 1.51B 28.3M Sep/2025
Hikma Pharmaceutical USD 642M 663M Jun/2025
Lonza CHF 3.09B 564M Dec/2024
Merck EUR 4.11B 117M Sep/2025
Novartis USD 9.86B 115M Sep/2025
Philips EUR 4.38B 405M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
RWE EUR 2.32B 715M Sep/2025
Sanofi EUR 10.51B 1.21B Dec/2025
Smith & Nephew USD 2.52B 84M Dec/2025